全文获取类型
收费全文 | 272篇 |
免费 | 32篇 |
出版年
2022年 | 2篇 |
2021年 | 5篇 |
2020年 | 2篇 |
2019年 | 5篇 |
2018年 | 1篇 |
2017年 | 4篇 |
2016年 | 6篇 |
2015年 | 12篇 |
2014年 | 16篇 |
2013年 | 16篇 |
2012年 | 22篇 |
2011年 | 23篇 |
2010年 | 10篇 |
2009年 | 10篇 |
2008年 | 15篇 |
2007年 | 13篇 |
2006年 | 20篇 |
2005年 | 14篇 |
2004年 | 15篇 |
2003年 | 6篇 |
2002年 | 13篇 |
2001年 | 4篇 |
2000年 | 5篇 |
1999年 | 6篇 |
1998年 | 8篇 |
1997年 | 3篇 |
1996年 | 1篇 |
1995年 | 4篇 |
1994年 | 3篇 |
1993年 | 2篇 |
1992年 | 3篇 |
1991年 | 2篇 |
1990年 | 2篇 |
1989年 | 3篇 |
1988年 | 2篇 |
1987年 | 2篇 |
1986年 | 1篇 |
1985年 | 4篇 |
1983年 | 1篇 |
1980年 | 4篇 |
1979年 | 1篇 |
1978年 | 4篇 |
1977年 | 1篇 |
1974年 | 1篇 |
1973年 | 1篇 |
1972年 | 1篇 |
1970年 | 1篇 |
1967年 | 1篇 |
1966年 | 1篇 |
1951年 | 1篇 |
排序方式: 共有304条查询结果,搜索用时 31 毫秒
1.
R Carmel M Linker-Israeli 《Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)》1988,188(1):77-81
Two IgG1K monoclonal antibodies to human transcobalamin II (TC II) were generated. These antibodies, 16.1 and 16.6, did not cross-react with the other two types of human cobalamin-binding proteins, intrinsic factor and R binder (TC I). Both antibodies cross-reacted with orangutan and simiang TC II but not with TC II from cynomolgus and howler monkeys, who are less closely related to humans. This finding suggests close structural similarity of human to ape TC II. The antibodies also did not react with TC II of lower mammals which included the horse, dog, guinea pig, and mouse; in particular, reaction did not occur with rabbit TC II, which has been considered structurally close to human TC II. Neither of the two antibodies was directed at the cobalamin-binding site of TC II. However, antibody 16.6 hindered TC II binding to cell receptor. This reactivity with the receptor-binding site should prove particularly useful in studies of that region of the TC II molecule. 相似文献
2.
3.
A weighted reversal potential, E, was defined as: . The concept was shown to be useful in describing threshold phenomena for single and multiple responses by providing explicit criteria which made possible the classification of responses into regenerative or non-regenerative. Within this framework E was also used to analyse the anodic break response and abolishment experiments. Using zero-duration (8-impulse) stimuli, the end of the absolutely refractory period was determined, according to the developed criteria, to be 3·17 t 0·01 ms after the peak of the spike, in the Hodgkin-Huxley model. 相似文献
4.
A method for the quantitative determination of tissue ferritin protein is described. It is based on the electroimmunoassay of Laurell [Laurell, C. B. (1966) Anal. Biochem.15, 45–52] and uses the iron content of ferritin for its identification. It measures as little as 0.1 μg of ferritin protein, requires only a few milligrams of tissue, and is rapidly performed. 相似文献
5.
6.
Carmel McDougall Felipe Aguilera Patrick Moase John S. Lucas Bernard M. Degnan 《Current biology : CB》2013,23(16):R671-R673
7.
Malaka Ameratunga Khashayar Asadi Xihui Lin Marzena Walkiewicz Carmel Murone Simon Knight Paul Mitchell Paul Boutros Thomas John 《PloS one》2016,11(4)
IntroductionImmune checkpoint inhibition has shifted treatment paradigms in non-small cell lung cancer (NSCLC). Conflicting results have been reported regarding the immune infiltrate and programmed death-ligand 1 (PD-L1) as a prognostic marker. We correlated the immune infiltrate and PD-L1 expression with clinicopathologic characteristics in a cohort of resected NSCLC.MethodsA tissue microarray was constructed using triplicate cores from consecutive resected NSCLC. Immunohistochemistry was performed for CD8, FOXP3 and PD-L1. Strong PD-L1 expression was predefined as greater than 50% tumor cell positivity. Matched nodal samples were assessed for concordance of PD-L1 expression.ResultsOf 522 patients, 346 were node-negative (N0), 72 N1 and 109 N2; 265 were adenocarcinomas (AC), 182 squamous cell cancers (SCC) and 75 other. Strong PD-L1 expression was found in 24% cases. In the overall cohort, PD-L1 expression was not associated with survival. In patients with N2 disease, strong PD-L1 expression was associated with significantly improved disease-free (DFS) and overall survival (OS) in multivariate analysis (HR 0.49, 95%CI 0.36–0.94, p = 0.031; HR 0.46, 95%CI 0.26–0.80, p = 0.006). In this resected cohort only 5% harboured EGFR mutations, whereas 19% harboured KRAS and 23% other. KRAS mutated tumors were more likely to highly express PD-L1 compared to EGFR (22% vs 3%). A stromal CD8 infiltrate was associated with significantly improved DFS in SCC (HR 0.70, 95%CI 0.50–0.97, p = 0.034), but not AC, whereas FOXP3 was not prognostic. Matched nodal specimens (N = 53) were highly concordant for PD-L1 expression (89%).ConclusionPD-L1 expression was not prognostic in the overall cohort. PD-L1 expression in primary tumor and matched nodal specimens were highly concordant. The observed survival benefit in N2 disease requires confirmation. 相似文献
8.
James?A. Poulter Manir Ali David?F. Gilmour Aine Rice Hiroyuki Kondo Kenshi Hayashi David?A. Mackey Lisa?S. Kearns Jonathan?B. Ruddle Jamie?E. Craig Eric?A. Pierce Louise?M. Downey Moin?D. Mohamed Alexander?F. Markham Chris?F. Inglehearn Carmel Toomes 《American journal of human genetics》2016,98(3):592
9.
10.